Contact: Bruno Larvol
Tel: 415.874.3310
Email: bruno.larvol@larvol.com

 
The Larvol Group to Participate in the Pharma CI Conference & Exhibition Europe 

San Francisco, CA – February 6, 2012 - The Larvol Group, LLC, a San Francisco-based competitive intelligence company, announced today that it will participate in the upcoming Pharma CI Conference & Exhibition on February 21st and 22nd in Zurich, Switzerland as both a sponsor and exhibitor. Company President, Bruno Larvol, will also be speaking at the conference. He will discuss the challenges that pharmaceutical companies face when attempting to monitor large volumes of secondary competitive intelligence information including news, corporate communication, conferences, trials, financial analyst reports and product milestones. Mr. Larvol will explore numerous options for mapping out competitor landscape activity and monitoring clinical trial and milestone developments . Mr. Larvol will present lessons learned from The Larvol Group’s experience in providing the industry with customized, integrated market intelligence reports.  

About The Larvol Group:

The Larvol Group, LLC, (www.larvol.com) founded in 2004, provides innovative business intelligence services for the pharmaceutical industry. Their Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, metabolic diseases, CNS, inflammation, cardiovascular, and pain management. Their customers include nine of the top 10 pharmaceutical companies.

For more information regarding this topic or to schedule an interview with Bruno Larvol, please contact Brandi Lambert at brandi.lambert@larvol.com at 816.665.7641. 

San Francisco, CA – August 24, 2011 - The Larvol Group, LLC, a San Francisco-based competitive intelligence company, announced today that they will participate in the upcoming Pharma CI Conference September 13th and 14th in Parsippany, New Jersey. Company President, Bruno Larvol will moderate a panel discussion entitled, “Social Media Monitoring: Mining the Web for Maximum Value in the Pharmaceutical Industry”. Together with industry experts from Bayer, Medtronic and Sanofi-Pasteur, Mr. Larvol will explore the role that social media plays in the pharmaceutical and biotech industries. Laura Farmer, Executive Vice-President of The Larvol Group will also present at the conference. She will discuss the use of Visual Tools to Map Competitor Landscapes & Trials.  

About The Larvol Group:

The Larvol Group, LLC, (www.larvol.com) founded in 2004, provides innovative business intelligence services for the pharmaceutical industry. Their Market Intelligence Reports track relevant news, clinical trials and developments in the competitive landscape of a given indication. Drawing on the knowledge of over 100 professionals, The Larvol Group has expertise in all major therapeutic areas, including oncology, metabolic diseases, CNS, inflammation, cardiovascular, and pain management. Their clients include nine of the top ten pharmaceutical companies.

For more information regarding this topic or to schedule an interview with Bruno Larvol, please contact Natalie Gulley at natalie.gulley@larvol.com at 512.426.1966